Results 71 to 80 of about 28,269 (176)
BMJ Open, 2019 Introduction Invasive meningococcal disease (IMD) primarily causes disease in young children and adolescents and can cause long-term disability. Many countries are considering implementation of meningococcal B and/or meningococcal ACWY vaccines to ...
David Gordon +10 more
doaj +1 more source
Societal costs due to meningococcal disease: a national registry-based study
ClinicoEconomics and Outcomes Research, 2018 Nina Gustafsson,1 Sandra Elkjær Stallknecht,1 Mette Skovdal,2 Peter Bo Poulsen,3 Lars Østergaard4 1Incentive, Holte, Denmark; 2Vaccines, Pfizer Denmark, Ballerup, Denmark; 3Health and Value, Pfizer Denmark, Ballerup, Denmark; 4Department of ...
Gustafsson N +4 more
doaj
Биопрепараты: Профилактика, диагностика, лечение, 2018 The present article describes clinical signs of meningococcal disease. It justifies the necessity of its vaccine prevention. The article provides with the historical data on the evolution of inoculants from corpuscular inactivated vaccines to modern ...
M. V. Abramtseva +2 more
doaj
Atypical meningococcal meningitis with rashless presentation: A case report
Journal of Acute Disease, 2012 Meningococcal disease is the major health problem in developing world. The clinical presentation is varied, ranging from transient fever and bacteraemia to fulminant disease with death ensuing within hours of the onset of clinical symptoms. The classical
Sunita, Manpreet Singh, Dheeraj Kapoor
doaj +1 more source
Therapeutics and Clinical Risk Management, 2008 Sanford R KimmelUniversity of Toledo College of Medicine, Department of Family Medicine, Toledo, OH, USAAbstract: Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant ...
Sanford R Kimmel
doaj
Human Vaccines & Immunotherapeutics, 2019 Invasive meningococcal disease (IMD) caused by Neisseria meningitidis is characterized by high mortality and morbidity. While IMD incidence peaks in both infants and adolescents/young adults, carriage rates are often highest in the latter age groups ...
Cynthia Burman +5 more
doaj +1 more source
Infection and Drug Resistance, 2011 Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M +3 more
doaj
Current safety issues with quadrivalent meningococcal conjugate vaccines
Human Vaccines & Immunotherapeutics, 2018 Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj +1 more source
Infectious diseases: meningococcal disease
Western Journal of Medicine, 2000 This article comes from Clinical Evidence (2000;3:350-357), a new resource for clinicians produced jointly by the BMJ Publishing Group and theAmerican College of Physicians—American Society of Internal Medicine.Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical ...
openaire +3 more sources
Журнал инфектологии, 2016 The article describes the clinical case of meningococcal infections, complicated with the development of reactive arthritis. It highlights possible pathogenetic mechanisms of aseptic inflammation in combined meningococcal and herpesvirus infections.
N. V. Skripchenko +3 more
doaj